Humana Inc. $HUM Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. lessened its stake in Humana Inc. (NYSE:HUM) by 13.6% in the 4th quarter, HoldingsChannel.com reports. The fund owned 12,783 shares of the insurance provider’s stock after selling 2,010 shares during the period. Pacer Advisors Inc.’s holdings in Humana were worth $3,274,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in HUM. Montag A & Associates Inc. increased its position in shares of Humana by 1,880.0% during the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC lifted its holdings in shares of Humana by 54.4% in the 4th quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock valued at $27,000 after purchasing an additional 37 shares during the last quarter. Fideuram Asset Management Ireland dac acquired a new stake in shares of Humana in the 4th quarter valued at about $27,000. Rosenberg Matthew Hamilton boosted its position in shares of Humana by 136.0% in the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after purchasing an additional 68 shares during the period. Finally, Larson Financial Group LLC boosted its position in shares of Humana by 114.1% in the 3rd quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after purchasing an additional 81 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. UBS Group reaffirmed a “neutral” rating on shares of Humana in a research report on Monday, June 15th. JPMorgan Chase & Co. increased their price objective on Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a report on Monday, June 8th. Zacks Research upgraded shares of Humana from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 13th. Bank of America lifted their target price on shares of Humana from $267.00 to $340.00 and gave the company a “neutral” rating in a report on Thursday, June 4th. Finally, Wolfe Research upgraded shares of Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $291.35.

Humana Price Performance

Humana stock opened at $359.99 on Wednesday. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $380.86. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The business has a 50 day simple moving average of $292.50 and a 200-day simple moving average of $243.15. The stock has a market capitalization of $43.22 billion, a PE ratio of 38.50, a price-to-earnings-growth ratio of 2.05 and a beta of 0.76.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The firm had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. Humana’s quarterly revenue was up 23.5% on a year-over-year basis. During the same period last year, the firm posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. Equities analysts predict that Humana Inc. will post 9.04 earnings per share for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.0%. Humana’s payout ratio is presently 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.